source
- Supreme Court hints skinny labeling may remain viable for generic drugsAt a hearing, Supreme Court justices heard arguments about skinny labeling, a practice used by generic manufacturers to seek approval for a subset of a brand drug's indications. The justices did n…
- Health AI discourse shifts from hype to practical discussion, says STAT newsletterBrittany Trang, a health‑tech reporter at STAT, reflects on how the conversation around artificial intelligence in healthcare is changing. In her AI Prognosis newsletter she notes that the industry…